Adaptive Biotechnologies Corporation Stock
Equities
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.83 USD | -2.66% |
|
-7.10% | -21.00% |
| May. 06 | Adaptive Biotechnologies Q2 Loss Narrows, Revenue Rises | MT |
| May. 05 | Adaptive Biotechnologies Corporation, Q1 2026 Earnings Call, May 05, 2026 |
| Capitalization | 2.05B 1.77B 1.62B 1.54B 2.83B 197B 2.87B 19.38B 7.5B 93.52B 7.71B 7.54B 326B | P/E ratio 2026 * |
-27.7x | P/E ratio 2027 * | -51.6x |
|---|---|---|---|---|---|
| Enterprise value | 1.94B 1.67B 1.52B 1.45B 2.67B 186B 2.71B 18.28B 7.07B 88.2B 7.27B 7.11B 307B | EV / Sales 2026 * |
6.75x | EV / Sales 2027 * | 5.39x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | -2.66% | ||
| 1 week | -7.10% | ||
| Current month | -9.01% | ||
| 1 month | -11.70% | ||
| 3 months | -20.01% | ||
| 6 months | -9.01% | ||
| Current year | -21.00% |
| 1 week | 12.81 | 14.1 | |
| 1 month | 12.81 | 15.15 | |
| Current year | 12 | 19.8 | |
| 1 year | 8.5 | 20.76 | |
| 3 years | 2.28 | 20.76 | |
| 5 years | 2.28 | 43.4 | |
| 10 years | 2.28 | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harlan Robins
CTO | Chief Tech/Sci/R&D Officer | 53 | 2009-09-07 |
Chad Robins
CEO | Chief Executive Officer | 51 | 2009-09-07 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 2024-04-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 2013-01-31 |
Peter Neupert
BRD | Director/Board Member | 70 | 2013-11-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.66% | -7.10% | +44.00% | +97.69% | 2.05B | ||
| -1.08% | -4.80% | +35.06% | +53.31% | 3.07B | ||
| -0.24% | -5.41% | -28.21% | -31.43% | 2.3B | ||
| -1.99% | -4.70% | +96.02% | -55.99% | 1.54B | ||
| -2.64% | +1.88% | +236.25% | - | 1.06B | ||
| -2.54% | -8.48% | +24.04% | +139.45% | 1.03B | ||
| -2.97% | +27.25% | -0.48% | +31.85% | 956M | ||
| -1.51% | -4.91% | -14.60% | -17.96% | 614M | ||
| -3.26% | -14.43% | +111.73% | -72.33% | 612M | ||
| -4.41% | -5.71% | - | - | 356M | ||
| Average | -2.33% | -5.02% | +55.98% | +18.07% | 1.36B | |
| Weighted average by Cap. | -1.85% | -5.26% | +46.48% | +26.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 287M 247M 226M 215M 395M 27.54B 402M 2.71B 1.05B 13.07B 1.08B 1.05B 45.55B | 352M 303M 277M 264M 484M 33.74B 492M 3.32B 1.28B 16.02B 1.32B 1.29B 55.8B |
| Net income | -72.3M -62.21M -56.88M -54.27M -99.49M -6.94B -101M -682M -264M -3.29B -271M -266M -11.47B | -38.59M -33.21M -30.36M -28.97M -53.11M -3.7B -53.99M -364M -141M -1.76B -145M -142M -6.12B |
| Net Debt | -117M -100M -91.86M -87.65M -161M -11.2B -163M -1.1B -426M -5.32B -438M -429M -18.53B | -157M -135M -123M -118M -215M -15.02B -219M -1.48B -572M -7.13B -587M -575M -24.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 12.83 $ | -2.66% | 1,563,597 |
| 26-05-14 | 13.18 $ | +0.38% | 1,600,088 |
| 26-05-13 | 13.13 $ | -3.67% | 1,285,899 |
| 26-05-12 | 13.63 $ | +0.66% | 1,233,353 |
| 26-05-11 | 13.54 $ | -1.96% | 1,505,374 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions

















